Alopecia areata is thought to be primarily driven by an immune attack at the hair follicle that leads to potentially reversible, non-scarring hair loss, but there’s still more to be discovered. Tune in to see what is currently thought to be the pathophysiology of alopecia areata, including the potential roles of the JAK and TEC kinase family signaling pathways.

© 2021 Pfizer Inc. All rights reserved. PP-RIL-USA-0023 October 2021